157 related articles for article (PubMed ID: 9711751)
1. Recurrent glioblastoma multiforme: potential benefits using fractionated stereotactic radiotherapy and concurrent taxol.
Lederman G; Arbit E; Odaimi M; Wertheim S; Lombardi E
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):162-74. PubMed ID: 9711751
[TBL] [Abstract][Full Text] [Related]
2. Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report.
Lederman G; Arbit E; Odaimi M; Lombardi E; Wrzolek M; Wronski M
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):661-6. PubMed ID: 9486617
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel.
Lederman G; Wronski M; Arbit E; Odaimi M; Wertheim S; Lombardi E; Wrzolek M
Am J Clin Oncol; 2000 Apr; 23(2):155-9. PubMed ID: 10776976
[TBL] [Abstract][Full Text] [Related]
4. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
[TBL] [Abstract][Full Text] [Related]
6. Fractionated stereotactic radiotherapy boost and weekly paclitaxel in malignant gliomas clinical and pharmacokinetics results.
Ashamalla H; Zaki B; Mokhtar B; Lewis L; Lavaf A; Nasr H; Colella F; Dosik D; Krishnamurthy M; Saad N; Guriguis A
Technol Cancer Res Treat; 2007 Jun; 6(3):169-76. PubMed ID: 17535024
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme.
Cho KH; Hall WA; Lo SS; Dusenbery KE
Technol Cancer Res Treat; 2004 Feb; 3(1):41-9. PubMed ID: 14750892
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma.
Landy H; Markoe A; Potter P; Lasalle G; Marini A; Savaraj N; Reis I; Heros D; Wangpaichitr M; Feun L
J Neurooncol; 2004; 67(1-2):215-20. PubMed ID: 15072470
[TBL] [Abstract][Full Text] [Related]
9. Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study.
Regine WF; Patchell RA; Strottmann JM; Meigooni A; Sanders M; Young B
J Neurosurg; 2000 Dec; 93 Suppl 3():37-41. PubMed ID: 11143260
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery for glioblastoma: a final report of 31 patients.
Masciopinto JE; Levin AB; Mehta MP; Rhode BS
J Neurosurg; 1995 Apr; 82(4):530-5. PubMed ID: 7897511
[TBL] [Abstract][Full Text] [Related]
11. Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme.
Romanelli P; Conti A; Pontoriero A; Ricciardi GK; Tomasello F; De Renzis C; Innocenzi G; Esposito V; Cantore G
Neurosurg Focus; 2009 Dec; 27(6):E8. PubMed ID: 19951061
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.
Maranzano E; Anselmo P; Casale M; Trippa F; Carletti S; Principi M; Loreti F; Italiani M; Caserta C; Giorgi C
Tumori; 2011; 97(1):56-61. PubMed ID: 21528665
[TBL] [Abstract][Full Text] [Related]
13. Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma.
Bir SC; Connor DE; Ambekar S; Wilden JA; Nanda A
Neurosurg Rev; 2015 Oct; 38(4):705-13. PubMed ID: 25864406
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme.
Einstein DB; Wessels B; Bangert B; Fu P; Nelson AD; Cohen M; Sagar S; Lewin J; Sloan A; Zheng Y; Williams J; Colussi V; Vinkler R; Maciunas R
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):668-74. PubMed ID: 22445005
[TBL] [Abstract][Full Text] [Related]
15. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA
Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131
[TBL] [Abstract][Full Text] [Related]
16. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
Kong DS; Nam DH; Lee JI; Park K; Kim JH
J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.
Cabrera AR; Cuneo KC; Vredenburgh JJ; Sampson JH; Kirkpatrick JP
J Natl Compr Canc Netw; 2012 Jun; 10(6):695-9. PubMed ID: 22679114
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel as a radiosensitizer combined with fractionated stereotactic radiotherapy in the treatment of recurrent medulloblastoma.
Gannett DE; Hill D; Hamilton AJ; Stea B
Am J Clin Oncol; 1997 Jun; 20(3):233-6. PubMed ID: 9167743
[TBL] [Abstract][Full Text] [Related]
20. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
